| |
 |
|
|
|
|
|
Poster: 200
Visits: 81
Title: Recombinant factor XIII is safe and effective for prophylaxis in young children with congenital FXIII A-subunit deficiency: results from the mentor5 international phase 3 trial
Authors: Susan Kearney , Susan L. Kearney, Aida Inbal, Andrew Will, Michael Williams, May-Lill Garly, Lotte Jacobsen, Bryce A. Kerlin
Centre: Pediatric Hematology/Oncology, Childrens Hospitals and Clinics of Minnesota, Minneapolis, MN, USA
|
|
You must be registered to reply or comment.
|
|
RECOMBINANT FACTOR XIII IS SAFE AND EFFECTIVE FOR PROPHYLAXIS IN YOUNG CHILDREN WITH CONGENITAL FXIII A-SUBUNIT DEFICIENCY: RESULTS FROM THE MENTOR5 INTERNATIONAL PHASE 3 TRIAL
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 199
Visits: 135
Title: Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates in Patients with Congenital Fibrinogen Deficiency: final analysis.
Authors: Lidija Bozickovic , Bruce A. Schwartz
Centre: Octapharma
|
|
|
|
